Farm Bill Program Decisions: What Fits Your Farm?

Jan 06, 2026

By Jonathan LaPorte and Molly Sears et.al

Farm managers will once again look to choose between Price Loss Coverage (PLC) and Agricultural Loss Coverage (ARC) for the 2026 production year. Deciding which program will offer the best risk protection for your farm can seem a bit complex. To aid you in making your Farm Bill decision, MSU Extension will be hosting a series of webinar programs as part of the Farm Policy and Risk Management Series.

The first session will take place on Tuesday, January 20, at 1:00 p.m., and the second session on Tuesday, February 10, at 6:30 p.m. These are repeat sessions focusing on corn, soybeans and wheat crops. Participants are encouraged to attend either or both sessions in order to better understand Farm Bill commodity program options.

MSU Extension experts will walk through the decision between Price Loss Coverage and Agricultural Risk Coverage program options. ARC-CO provides revenue-based payments when farm revenue falls below a coverage guarantee level. The PLC program provides price-based payments when prices are less than a reference price. Speakers will also provide information on Farm Bill-related updates for insurance, commodity programs, and more.

Source : msu.edu

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.